Baseline metabolites could predict responders with hepatitis B virus-related liver fibrosis for entecavir or combined with FuzhengHuayu tablet

Figure 4 Bubbleplot of the selected metabolites pathways. A: Bubbleplot of entecavir responders (E-R) vs entecavir no-responders (E-N) (training set); B: Bubbleplot of FuzhengHuayu tablet (FZHY) + entecavir responders (F-R) vs FZHY + entecavir no-responders (F-N) (training set); C: Bubbleplot of patients vs volunteers (training set); D: Bubbleplot of E-R vs E-N (validation set); E: Bubbleplot of F-R vs F-N (validation set); F: Bubbleplot of patients vs volunteers (validation set). TCA: Tricarboxylic acid.